Autologous bone marrow-derived mononuclear cells (BM-MNC) with liberation therapy for CCSVI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous bone marrow-derived mononuclear cells (BM-MNC) with liberation therapy for CCSVI, covering 2015-10-28 to 2015-10-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS [Phase 1, Phase 2]